$INDI

Wu Naixi sold $30K of INDI

Wu Naixi (Chief Financial Officer) sold 6,000 shares of indie Semiconductor, Inc. (INDI) at $4.94 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wu Naixi
Published Jun 3, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 10:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INDI
Neutral
medium confidence
Mentioned
$INDI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INDINeutralLow
01

Why it matters

The disclosed sale provides transparency on insider liquidity/positioning but does not, by itself, indicate a change in company fundamentals given the pre-arranged nature.

02

Market read

For INDI, this is a routine insider transaction disclosure; any trading reaction is likely muted unless paired with other catalysts.

03

What to watch

The dollar amount is relatively small versus typical institutional flows; without context on prior insider patterns, the signal may be overstated.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 3 for a June 1 sale

Background

The article is an SEC EDGAR disclosure of an officer’s insider transaction (Form 4), including whether the sale was executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$INDINeutralMedium confidence
Context

Indie Semiconductor CFO Wu Naixi sold 6,000 shares in an open-market transaction disclosed via SEC Form 4 on June 1 under a 10b5-1 plan.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.

Evidence & confidence

The filing specifies a Rule 10b5-1 pre-arranged plan, which reduces the informational content versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no stated operational or regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with periods of valuation concern; traders may still watch for follow-on discretionary sales.

Key entities

  • indie Semiconductor, Inc.

    Company whose CFO disclosed an open-market sale of shares via SEC Form 4.

  • Wu Naixi

    Chief Financial Officer who sold 6,000 shares on June 1 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KRMNMed

OC Aerospace, Tech Companies Report Booming Sales

Karman Holdings (NYSE: KRMN) raised its FY2026 revenue outlook to $730M-$745M after Q2 revenue rose 58% to $182M, beating expectations. The article also summarizes earnings for TTM Technologies (TTMI), Viant Technology (DSP), Ducommun (DCO), Indie Semiconductor (INDI), and Clean Energy Fuels (CLNE), citing revenue and guidance figures.

$INDIMedAI 8/10

Indie Semi Jumps on Revenue Increase

Indie Semiconductor (Nasdaq: INDI) shares rose 16% to $4.00 in after-hours after reporting 24% higher Q2 revenue versus the same period in 2025. For the current quarter, it expects revenue of $67 million to $73 million, implying about 30% YoY growth at the midpoint.

$INDIHigh

indie Semiconductor, Inc. (INDI): Results of Operations and Financial Condition

indie Semiconductor, Inc. (INDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 indie Reports Second Quarter 2026 Results • Delivers Revenue of $64M, up 24% Y-o-Y and exceeds midpoint of the guidance range • Guides for accelerating growth of 30% Y-o-Y in Q3 2026 • Substantially narrows GAAP and Non-GAAP Operating Losses • Gains global OEM adopti

$HIVEMedAI 8/10

Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy

The article says US small-cap and penny stocks are benefiting from AI-driven risk appetite, citing the Russell 2000’s 16% YTD outperformance. It lists “Top 10” penny stocks under $5, using S&P 500 10% YTD outperformance, >20% upside, and hedge-fund holdings. For HIVE (share $4.54), it reports FY2026 revenue $297.8M (+158%) and adjusted EBITDA $72.9M. For indie Semiconductor (share $4.93), Benchmark reiterates Buy and an $8 target after a €40M acquisition of ams OSRAM’s CMOS image sensor business